AbbVie's Cariprazine Met Primary Endpoint in Phase 3 Study as an Adjunctive Treatment for Major Depressive Disorder Pharmaceutical Investing
Clinical and Patient-Reported Outcomes in People Living With HIV on Biktarvy® in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting Pharmaceutical Investing
Gilead Announces Clinical Trial Collaboration With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in Patients With First-Line Metastatic Triple-Negative Breast Cancer Pharmaceutical Investing
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bristol-Myers Squibb Company and Encourages Investors with Losses to Contact the Firm Pharmaceutical Investing
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bristol-Myers Squibb Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Pharmaceutical Investing
AbbVie Announces ABBV-951 Showed Improvement in Controlling Motor Fluctuations Compared to Oral Levodopa/Carbidopa Medication in Pivotal Phase 3 Trial in Patients with Advanced Parkinson's Disease Pharmaceutical Investing
HempFusion Launches Ingestible and Topical CBD Products into Major Arizona Grocer Cannabis Investing News
